<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-ijerph-16-01078">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vardeny</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Udell</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Joseph</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Farkouh</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Hernandez</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>McGeer</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Talbot</surname>
    <given-names>H.K.</given-names>
   </name>
   <name>
    <surname>Bhatt</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Cannon</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Goodman</surname>
    <given-names>S.G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the invested trial</article-title>
  <source>Am. Heart J.</source>
  <year>2018</year>
  <volume>202</volume>
  <fpage>97</fpage>
  <lpage>103</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ahj.2018.05.007</pub-id>
  <pub-id pub-id-type="pmid">29909156</pub-id>
 </element-citation>
</ref>
